English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Chikungunya virus infection is an emerging arbovirus disease. While many infected individuals recover after primary illness, others suffer from persistent debilitating arthralgia that can last for months to years. Currently, there are no immune correlates, vaccines, therapies or robust diagnostics that can affectively prevent, treat or diagnose Chikungunya. Therefore, this study focuses on development of a better diagnostic assay for Chikungunya infection.

Cloning, expression and purification of Chikungunya virus E2 recombinant protein in E.coli